Related Experiment Videos
[Dor operation for end-stage ischemic cardiomyopathy]
1Department of Cardiovascular Surgery, Shonan-Kamakura General Hospital, Kanagawa.
Journal of Cardiology
|April 29, 1998
Summary
The Dor operation effectively treats end-stage ischemic cardiomyopathy by excluding akinetic areas, improving ejection fraction and reducing heart failure symptoms in surgical candidates.
Area of Science:
- Cardiovascular Surgery
- Cardiology
- Cardiac Surgery
Context:
- End-stage dilated ischemic cardiomyopathy presents significant challenges in treatment.
- Patients often have reduced ejection fraction and severe heart failure symptoms.
- The Dor operation offers a potential surgical solution for these complex cases.
Purpose:
- To evaluate the efficacy of the endoventricular circular patch plasty (Dor operation) in treating end-stage dilated ischemic cardiomyopathy.
- To assess the perioperative and long-term outcomes of the Dor procedure combined with other cardiac surgeries.
Summary:
- The Dor procedure was performed on 13 patients with end-stage ischemic cardiomyopathy, often combined with coronary artery bypass grafting and mitral valve surgery.
- No perioperative deaths occurred, and while three in-hospital deaths were reported, survivors showed significant improvements.
- Ejection fraction increased from 22% to 36%, with reduced ventricular volumes and pulmonary capillary wedge pressure post-surgery.
Impact:
- The Dor operation demonstrates effectiveness in improving cardiac function and New York Heart Association (NYHA) class in patients with severe ischemic cardiomyopathy.
- It serves as a viable surgical alternative for patients who might otherwise be candidates for heart transplantation.
- The procedure leads to significant functional recovery and reduced heart failure burden.